Start-ups

BioM for start-ups

We guide you from idea to success

BioM GmbH offers extensive and individual support to start-ups and young entrepreneurs in medical biotechnology. We support you in developing a viable business model and in setting up a plausible business plan. We help you to identify the right financing and funding opportunities. In addition to our many years of experience, we provide you with a comprehensive network of industry representatives, investors and other relevant stakeholders. Together with our partners, we support you from your research idea to your successful start-up.

„Biotechnology founders are the essence of our entrepreneurial ecosystem. They are the drivers of converting ideas into innovation-based success schemes.“
Prof. Dr. Ralf Huss, Managing Director of BioM and spokesman of the Bavarian Biotechnology Cluster.


MAxL

MAxL

MAxL - Munich Accelerator Life Sciences & Medicine
BioM's unique co-creation start-up incubator for the future of medicine and life sciences.

More Information


Mentor Circle

Mentor Circle

BioM provides experienced mentors who support founders in an honorary capacity.

More Information


Pitch Training

Pitch Training

Coaching for a more professional presentation of founding projects and start-ups 

More Information



BioEntrepreneur Lounge

BioEntrepreneur Lounge

Regular networking event for start-ups and young entrepreneurs

More Information


BioAngels

BioAngels

Exclusive meeting on the campus between investors and start-up teams

More Information


m4 Award

m4 Award

The Bavarian pre-seed funding program addresses academic research projects with spin-off potential in medical biotechnology.

More Information


Links

Links

Founder programs and useful links for start-ups

More Information

Dr. Petra Burgstaller
Dr. Petra Burgstaller

Incubation & MAxL Co-Lead, Portfolio Management


Christina Enke-Stolle
Christina Enke-Stolle

Incubation & MAxL Co-Lead, Partnership Management


More about this topic

BIO-Europe 2024 in Stockholm, Sweden: Join us at the German Pavilion!

BIO-Europe 2024: Out­stand­ing Offer at the Ger­man Pavil­ion – Se­cure Your Spot Now!This fall, BIO-Europe re­turns for an en­rich­ing…

Eisbach Bio announces FDA clearance of IND application for EIS-12656, a first-in-class allosteric inhibitor of ALC1

Eis­bach Bio GmbH, a privately-held clin­ic­al-stage bi­o­tech­no­logy com­pany in Martin­sried pi­on­eer­ing can­cer medi­cines lever­aging…